depression

News

NICE backs digital CBT for youngsters with depression

NICE has recommended digital cognitive behavioural therapy (CBT) should be used as a first-line treatment for children and young people with mild depression.

News

Otsuka funds prescription therapy app for depression

Otsuka is once again betting on digital as a new avenue for depression treatment by collaborating with Click Therapeutics to develop and commercialise a ‘prescriptio

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J preps for FDA panel grilling over depression drug

Johnson & Johnson is “confident” about regulatory reviews of its depression drug esketamine ahead of a likely grilling by FDA experts – even though two of the five trials it is relying

News

J&J files esketamine nasal spray antidepressant in US

Drug targets 30% of people who don't respond to approved treatments

News

Mixed phase 3 results from J&J's esketamine depression drug

Drug missed efficacy endpoint in older population

News

Janssen's depression drug shows promise in phase 2

Ketamine may be best known as an anaesthetic illegally used as a party drug, but Janssen has shown that it could also be reformulated and used as a treatment for depression.

NICE backs digital CBT for youngsters with depression

Otsuka funds prescription therapy app for depression

J&J preps for FDA panel grilling over depression drug

J&J files esketamine nasal spray antidepressant in US

Mixed phase 3 results from J&J's esketamine depression drug

Janssen's depression drug shows promise in phase 2

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

depression

Editor's Picks